Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05).
暂无分享，去创建一个
Y. Kakeji | K. Tanabe | M. Takeuchi | K. Chìn | W. Ichikawa | C. Kunisaki | M. Fujii | K. Tanabe | M. Terashima | T. Nakajima | A. Tsuji | K. Nishikawa | N. Matsuhashi | K. Yoshida | T. Kawase | M. Kochi | A. Takagane | T. Ohno | T. Kawase | K. Chin | Kensaku Yoshida